ARROWHEAD PHARMACEUTICALS, INC. Utilities Costs (Deprecated 2018-01-31)
ARROWHEAD PHARMACEUTICALS, INC. (ARWR) reported Utilities Costs (Deprecated 2018-01-31) of $15.00 thousand for the 9-month period ending 2014-06-30, per its 10-Q filed 2014-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:UtilitiesCosts · last filed 2014-08-12
- ARROWHEAD PHARMACEUTICALS, INC. utilities costs (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $1.00K.
- ARROWHEAD PHARMACEUTICALS, INC. utilities costs (deprecated 2018-01-31) for the quarter ending 2014-03-31 was -$1.00K.
- ARROWHEAD PHARMACEUTICALS, INC. utilities costs (deprecated 2018-01-31) for the quarter ending 2013-12-31 was $15.00K, a 6.25% decline year-over-year.
- ARROWHEAD PHARMACEUTICALS, INC. utilities costs (deprecated 2018-01-31) for the quarter ending 2013-09-30 was -$1.00K.
- ARROWHEAD PHARMACEUTICALS, INC. utilities costs (deprecated 2018-01-31) for fiscal 2013 was $15.00K, a 6.25% decline from fiscal 2012.
- ARROWHEAD PHARMACEUTICALS, INC. utilities costs (deprecated 2018-01-31) for fiscal 2012 was $16.00K.
| Period end | Utilities Costs (Deprecated 2018-01-31) 1 month | Utilities Costs (Deprecated 2018-01-31) 3 month | Utilities Costs (Deprecated 2018-01-31) 6 month | Utilities Costs (Deprecated 2018-01-31) 9 month | Utilities Costs (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|
| 2014-06-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-08-12 | $0.00 derived: sum of 2 quarters · filed 2014-08-12 | $15.00K 10-Q · filed 2014-08-12 | $14.00K derived: sum of 4 quarters · filed 2014-08-12 | |
| 2014-03-31 | -$1.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-05-06 | $14.00K 10-Q · filed 2014-05-06 | $13.00K derived: sum of 3 quarters · filed 2014-05-06 | $13.00K derived: sum of 4 quarters · filed 2014-05-06 | |
| 2013-12-31 | $15.00K 10-Q · filed 2014-02-04 | $14.00K derived: sum of 2 quarters · filed 2014-02-04 | $14.00K derived: sum of 3 quarters · filed 2014-02-04 | $14.00K derived: sum of 4 quarters · filed 2014-02-04 | |
| 2013-09-30 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-12-18 | -$1.00K derived: sum of 2 quarters · filed 2013-12-18 | -$1.00K derived: sum of 3 quarters · filed 2013-12-18 | $15.00K 10-K · filed 2013-12-18 | |
| 2013-06-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-08-07 | $0.00 derived: sum of 2 quarters · filed 2013-08-07 | $16.00K 10-Q · filed 2013-08-07 | ||
| 2013-03-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-05-09 | $16.00K 10-Q · filed 2013-05-09 | |||
| 2012-12-31 | $16.00K 10-Q · filed 2013-02-13 | ||||
| 2012-09-30 | $16.00K 10-K · filed 2012-12-28 | ||||
| 2012-06-30 | $16.00K 10-Q · filed 2012-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 |